associate sponsors

Havells
HDFC

Eris Lifesciences to make bourse debut on June 29

New Delhi: Eris Lifesciences is set to debut on the stock market on Thursday after concluding its initial public offer (IPO) last week.

BSE

The company’s IPO was subscribed 3.29 times during 16-20 June. The portion set aside for qualified institutional buyers (QIBs) was oversubscribed 4.68 times, non institutional investors 45 percent and retail investors 3.51 times.

The price band for the share sale was fixed at Rs600- 603. The book running lead managers to the offer were Axis Capital, Citigroup Global Markets India and Credit Suisse Securities (India).

Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas


Updated Date: Jun 28, 2017 15:36 PM

Also Watch

Social Media Star: Abhishek Bachchan, Varun Grover reveal how they handle selfies, trolls and broccoli
  • Monday, July 16, 2018 It's a Wrap: Soorma star Diljit Dosanjh and Hockey legend Sandeep Singh in conversation with Parul Sharma
  • Monday, July 16, 2018 Watch: Dalit man in Uttar Pradesh defies decades of prejudice by taking out baraat in Thakur-dominated Nizampur village
  • Monday, July 16, 2018 India's water crisis: After govt apathy, Odisha farmer carves out 3-km canal from hills to tackle scarcity in village
  • Sunday, July 15, 2018 Maurizio Sarri, named as new Chelsea manager, is owner Roman Abramovich's latest gamble in quest for 'perfect football'

Also See